Enrofloxacin Levels Research Articles

MIPs–SERS Sensor Based on Ag NPs Film for Selective Detection of Enrofloxacin in Food

The quinolone antibiotics represented by enrofloxacin (ENRO) are harmful to the ecological environment and human health due to illegal excessive use, resulting in increasing food residues and ENRO levels in the environment. To this end, we developed a MIPs-SERS method using surface-enhanced Raman spectroscopy (SERS) and molecularly imprinted polymers (MIPs) to detect ENRO in food matrices. Firstly, a layer of silver nanoparticles (Ag NPs) with the best SERS effect was synthesized on the surface of copper rods as the enhancing material by in situ reductions, and then MIPs targeting ENRO were prepared by the native polymerization reaction, and the MIPs containing template molecules wrapped on the surface of silver nanoparticle films (Ag NPs-MIPs) were obtained. Our results showed that the Ag NPs-MIPs could specifically identify ENRO from the complex environment. The minimum detection limit for ENRO was 0.25 ng/mL, and the characteristic peak intensity of ENRO was linearly correlated to the concentration with a linear range of 0.001~0.1 μg/mL. The experimental results showed that in comparison to other detection methods, the rapid detection of ENRO in food matrices using Ag NPs-MIPs as the substrate is reliable and offers a cost-effective, time-saving, highly selective, and sensitive method for detecting ENRO residues in real food samples.

Effects of lactic acid on drug-metabolizing enzymes in Chinese mitten crab (Eriocheir sisnensis) after oral enrofloxacin

Enrofloxacin (ENR) is the most commonly used antibiotic in crustacean farming in China. Diet supplementation with lactic acid (LA) may, however, affect the efficacy and safety of ENR-based drugs. The aims of this study were to investigate the effects of LA on drug residues and elimination of oral ENR in Chinese mitten crab (Eriocheir sinensis) and to determine ENR and gene expression levels of drug-metabolizing enzymes in the hepatopancreas. To this end, ENR was orally administered to the crabs at a dose of 10.0 mg kg−1 body weight on the eighth day after feeding diets supplemented with 0.3%LA. The results showed that ENR levels in the hepatopancreas were significantly different at 1 and 12 h between the ENR and ENR + 0.3% LA groups (P < 0.05). Lactic acid did not significantly affect the expression of CYP2A (phase I). However, the expressions of CYP3 (phase I) and GST (phase II) were significantly up-regulated by LA during the elimination process of ENR (6–24 h). At Tmax (1 h), the expression of phosphoenolpyruvate carboxykinase (PEPCK) was induced and expression of succinate dehydrogenase (SDH) was inhibited by LA. Both of these enzymes were significantly inhibited during the elimination process of ENR. The results suggest that LA contributes to the elimination of ENR, and thus, enhances hepatopancreas biotransformation and anti-injury capacity in E. sinensis.

ENROFLOXACIN RESIDUES IN CHICKEN MEAT AND GIBLETE

It is very important to achieve the safety and sanitary quality of the meat as the presence of antibiotic residues in food stuff can cause hazards to human so that the aim of this study is evaluation the level of enrofloxacin residues in chicken meat and giblets and the effect of different cooking methods on reduction of these levels.One hundred and twenty random samples of chicken breast, thigh, gizzard and liver (30 of each) were collected from different chicken slaughter shops located in Menoufia government for evaluation of their enrofloxacin residues. The collected samples were examined by using microbiological inhibition technique (MIT) and High Performance Liquid Chromatography (HPLC) in addition to the effect of heat treatment (boiling, grilling and frying) on these residues was studied. The obtained results revealed that the incidence of enrofloxacin residues in chicken breast, thigh, gizzard and liverwere 13.33%, 16.67%, 26.67% & 40% by MIT and 13.33%, 20%, 30% & 43.33% by HPLC, respectively. The results indicated that 85% of the examined samples not exceeded the MRL of enrofloxacin residues. The reduction% of enrofloxacin levels in thigh muscle samples was 28.3%, 17.8% &11.2by boiling57.4%, 43.6% &35.2%by frying and69.5%, 62.4% & 47.7% by grilling of such samples. The public health significance and some recommendations to control such antibiotic residue in chicken tissues for human safety were discussed.

Environmental contaminants in fish species from a large dam reservoir and their potential risks to human health

The residue levels of antibiotics, metals and organochlorine pesticides (OCPs) were investigated in six fish species from the Karakaya Dam Reservoir, Turkey. Among monitored antibiotics, only enrofloxacin and ofloxacin were detected in muscle of fish species. Enrofloxacin levels in positive samples ranged from 0.0034 to 0.0073 mg/kg. It was detected in four fish species (trout barb, common carp, chub and Euphrates barbell), while ofloxacin was only found in common carp with the concentration of 0.0072 mg/kg. Both enrofloxacin and ofloxacin levels were below the maximum residue levels. No detectable residues of any OCPs were found in fish species. The highest toxic metal (As, Cd and Pb) content was detected in Euphrates barbell (0.103 mg/kg). Arsenic, Cd, Cr, Cu, Pb and Zn levels were well below the maximum permissible limits. The levels of antibiotics and metals found in fish species in the present study were generally lower than or comparable to those reported in other water bodies. According to estimated daily intake and hazard quotient values, antibiotics and metals detected in these wild fish species do not appear to pose a serious risk to public health.

Enrofloxacin stimulates cell death in several tissues of vannamei shrimp (Litopenaeus vannamei)

The aim of this research was to investigate the effect of enrofloxacin on vannamei shrimp (Litopenaeus vanammei) by measuring its accumulation and withdrawal time, in addition to its histopathological effects. The effect of enrofloxacin on the cells of vannamei shrimp has not yet been reported. The enrofloxacin levels were analysed by enzyme-linked immunosorbent assay (ELISA), and several tissues and organs, including the hepatopancreas, gills and muscles, were histopathologically analysed. Regarding the withdrawal time from shrimp tissue, the optimum enrofloxacin dose is 26.06 ± 13.67 μg/kg. The greatest enrofloxacin-induced damage was observed in the hepatopancreas, in which necrosis, aggregate transformed microvilli, atrophy, inflammatory cell infiltration and plasma leaking from blood vessels were observed. In addition, necrosis was found in the muscle tissue. However, no damage was found in the gills, and enrofloxacin did not affect the lymphoid organ, midgut caeca or gastric organ.

Rule of accumulation of enrofloxacin in Acipenser baerii and drug-induced damage to the tissues.

Enrofloxacin (ENX) has been widely used in the prevention and control of bacterial diseases in sturgeon aquaculture due to its characteristics of wide antibacterial spectrum, strong antibacterial activity, less toxicity and fewer side effects, rapid action, extensive invivo distribution, and little cross-resistance with other antibiotics. However, the spinal abnormality was found in Acipenser baerii soon after ENX administration, which resulted an "S"-shaped curvature of the spine and retarded fish growth. It was still not clear whether ENX could cause spinal abnormality in sturgeons by now. The aim of this work was to determine the accumulation rule and toxicity of ENX to A. baerii when used at a high dose and/or unusually long durations. Here, ENX was orally given to A. baerii for 3-5 d continuously at the dosage of 0, 20, 40, and 80 mg/kg once daily, respectively. The accumulation of ENX in blood, liver, kidney, and cartilage was detected after withdrawal, and the tissues were made into sections for morphological examination. The results showed that the levels of ENX increased in the four tissues with the increase of dose and duration, and the ENX level in serum was far lower than that in other tissues. At 240 h, ENX levels in the four tissues decreased significantly. The histology indicated that the liver, kidney, and cartilage began to show structural damages at 5 d after withdrawal of 40 mg/kg ENX. The damage was aggravated at 3-5 d after withdrawal of 80 mg/kg ENX. At 240 h, the damaged tissues showed signs of recovery. These results suggested that ENX should be no more than 40 mg/kg and that exposure time should not be greater than 5 d to prevent liver, kidney, and cartilage damage. More attention should be paid to the impact of ENX on the occurrence and development of chondrocytes in juvenile A. baerii and the potential damage to the cartilage.

Effect of Storage on Residue Levels of Enrofloxacin in Muscle of Rainbow Trout (Oncorhynchus mykiss) and Common Carp (Cyprinus carpio)

Abstract Since fluoroquinolones are one of the most commonly used antibacterial drugs in aquaculture, there is a risk of their residues to be found in the treated fish. The objective of this study was to examine the changes in enrofloxacin and ciprofloxacin levels during storage of rainbow trout and common carp muscle at −18 °C. The trout and carp were treated orally with a single dose of 10 mg/kg of enrofloxacin. Tissue samples were collected 24 h after the treatment and stored at −18 °C for 270 days either as a whole fish or as precut muscle samples. Results for trout revealed that in the precut samples enrofloxacin concentration decreased significantly only after 9 months of storage, whereas a significant decline in the ciprofloxacin level was observed much earlier (after 3 months). After 9 months of storage, the trout stored without being sliced and eviscerated showed significantly higher levels of both quinolones as compared to the precut muscle samples. The enrofloxacin levels in the carp musculature decreased considerably after 3 months of storage and stayed almost unchanged up to the end of the study, whereas the ciprofloxacin concentration continued to drop even after this period and after 270 days constituted 1/6 of the initial values.

Residue levels of enrofloxacin and ciprofloxacin in processed animal by-products used in Atlantic salmon feeds and their long-term carry-over to the edible part of the fish

Residue levels of the antibacterials enrofloxacin and ciprofloxacin were analysed in 15 commercially relevant animal by-products (ABPs). Enrofloxacin was detected in all ABPs, and ciprofloxacin was detected in 11 of 15 ABP samples. Feed to muscle and skin carry –over of low background enro- and ciprofloxacin levels were assessed by applying a simple toxicokinetic model. The muscle and skin uptake and elimination rates were established in Atlantic salmon (Salmo salar L.) fed enrofloxacin enriched diets (100 μg kg−1 ‘low’ and 4000 μg kg−1 ‘high’) in triplicate for 41 days followed by a 90 days depuration period. The terminal half-lives were 17 ± 0.4 and 18 ± 0.7 days, and uptake rates were 9.3 ± 3.3 and 11 ± 3.1 (day−1) for the ‘low’ and ‘high’ groups, respectively. Only fish fed high background levels had quantifiable levels of the metabolite ciprofloxacin with a formation of 0.25 ± 0.01% day−1. The toxicokinetic carry-over model predicted muscle and skin steady state levels of 1.8 μg kg−1 when fed theoretically high enrofloxacin levels (158 μg kg−1), which is below the EU limit of 100 μg kg−1 for enrofloxacin in finfish food products. The antibacterial residue levels could however be detected in EU food surveillance programmes.

The disposition of enrofloxacin in seabream ( Sparus aurata L.) after single intravenous injection or from medicated feed administration

Serum concentrations of enrofloxacin (EF) after intravenous (i.v.) or oral administration of single doses (2.5 and 10 mg/kg b.w., respectively) were investigated in seabream ( Sparus aurata L.) kept in seawater at 25–27 °C. The tissue disposition of the drug was studied after oral administration. At prefixed time points, from 1 h to 5 days after administration, blood and edible tissues (muscle plus adherent skin) from 10 individuals in each group were collected and stored at −20 °C. Each serum and tissue sample was essayed for EF by HPLC after liquid–liquid extraction. Serum was also checked for the presence of the metabolite ciprofloxacin (CF). The quantification limits for EF were 0.010 μg/ml in serum and 0.015 μg/g in tissues. Following intravenous administration, considerably high serum concentrations of EF (range 2.605–3.810 μg/ml) were detected during the first 4 h. The concentrations decreased subsequently, indicating a first rapid distribution, followed by a slow phase of elimination. At the last time point of the experiment (120 h), there were still detectable amounts of EF in serum samples (range 0.040–0.087 μg/ml). Enrofloxacin levels of 0.335–1.138 μg/ml were reached in serum within 1 h after in feed administration. The maximum values were measured at 8 h (1.709–2.846 μg/ml), then slowly declined and were measurable (0.048–0.149 μg/ml) for up to 120 h. Compared to serum, lower concentrations of EF were determined in muscle plus skin: 0.156–0.398 μg/g after 1 h, 0.102–2.002 μg/g at 8 h and 0.015–0.031 μg/g at the last sample point. No CF was found in serum.

Disposition of Enrofloxacin in Red-tailed Hawks (Buteo jamaicensis) and Great Horned Owls (Bubo virginianus) after a Single Oral, Intramuscular, or Intravenous Dose

Enrofloxacin is a fluoroquinolone antibiotic that is effective against many of the common gram-negative bacterial pathogens in raptors. This 3-period crossover study was designed to compare the pharmacokinetics of enrofloxacin after oral, intramuscular, or intravenous administration in red-tailed hawks (Buteo jamaicensis; n = 8) and great horned owls (Bubo virginianus; n = 5). In each study period, birds received a single dose of an injectable formulation of enrofloxacin (15 mg/kg) by 1 of these 3 routes. Oral administration was accomplished by force-feeding each bird a small freshly killed mouse that had received an intraperitoneal injection of enrofloxacin (in-prey). Intramuscular injections were divided into 2 sites in the pectoral musculature. Serial plasma samples were taken before administration and at 0.25, 0.5, 1, 2, 4, 8, 12, 24, and 48 hours after administration. Oral administration resulted in plasma concentrations of enrofloxacin that peaked at 4–8 hours in both species. Plasma concentrations remained at >1 μg/ml until at least 18 hours after administration, although an initial lag time of approximately 2–8 hours occurred for absorption from the gastrointestinal tract. Intramuscular administration resulted in plasma concentrations that peaked at 0.5–2 hours; enrofloxacin levels remained at >1 μg/ml for at least 15 hours. After intravenous administration to red-tailed hawks, enrofloxacin levels remained at >1 μg/ml for at least 15 hours. Two great horned owls showed acute weakness, bradycardia, and peripheral vasoconstriction during intravenous injection. These clinical signs resolved within 1–3 hours with supportive therapy; however, the intravenous route was not evaluated for the other 3 owls. We conclude that oral (in-prey) and intramuscular routes are reliable means of administration of injectable enrofloxacin in red-tailed hawks and great horned owls, using a dosage of 15 mg/kg q24h. Intravenous administration of enrofloxacin can be performed with caution in red-tailed hawks but should not be attempted in great horned owls.